Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in

被引:0
|
作者
Kuo, Li-Kuo [1 ,2 ]
Chang, Hou-Tai [3 ,4 ]
Hsueh, Shun-Chung [5 ]
Liu, Min [6 ]
Hsieh, Po-Chuen [6 ]
Jean, Shio-Shin [6 ,7 ,8 ]
机构
[1] Mackay Med Coll, Dept Med, New Taipei, Taiwan
[2] Mackay Mem Hosp, Dept Crit Care Med, Taipei, Taiwan
[3] Far Eastern Mem Hosp, Dept Crit Care Med, New Taipei, Taiwan
[4] Yuan Ze Univ, Dept Ind Engn & Management, Taoyuan, Taiwan
[5] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei, Taiwan
[6] Tajen Univ, Coll Pharm & Hlth Care, Dept Pharm, Pingtung 90741, Taiwan
[7] Min Sheng Gen Hosp, Dept Internal Med, 168 Ching Kuo Rd, Taoyuan 330, Taiwan
[8] Min Sheng Gen Hosp, Dept Crit Care Med, 168 Ching Kuo Rd, Taoyuan 330, Taiwan
关键词
Healthcare- associated pneumonia; Multidrug-resistant; Klebsiella pneumoniae; Acinetobacter baumannii complex; Pseudomonas aeruginosa; PSEUDOMONAS-AERUGINOSA; INFECTIONS;
D O I
10.1016/j.jmii.2024.07.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To understand the microbial profile and investigate the independent predictors for healthcare-associated pneumonia (HCAP) pertinaciously caused by isolates of multidrug-resistant (MDR) Gram-negative bacteria (GNB). Methods: Multicenter ICU patients who received appropriate antibiotic treatments for preceding pneumonia due to MDR GNB isolates and subsequently developed HCAP caused by either MDR GNB (n = 126) or non-MDR GNB (n = 40) isolates in Taiwan between 2018 and 2023 were enrolled. Between the groups of patients with HCAP due to MDR GNB and non-MDR GNB, the proportions of the following variables, including demographic characteristics, important co- morbidities, nursing home residence, physiological severity, intervals between two hospitalizations, steroid use, the tracheostomy tube use alone, ventilator support, and the predominant GNB species involving HCAP, were analyzed using the chi-square test. Logistic regression was employed to explore the independent predictors for HCAP persistently caused by MDR GNB in the aforementioned variables with a P-value of <0.15 in the univariate analysis. Results: MDR-Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii complex were the three predominant species causing HCAP. Chronic structural lung disorders, diabetes mellitus, intervals of <30 days between two hospitalizations, use of the tracheostomy tube alone, and prior pneumonia caused by MDR A. baumannii complex were shown to independently predict the HCAP tenaciously caused by MDR GNB. Conversely, the preceding pneumonia caused by MDR P. aeruginosa was a negative predictor. Conclusion: Identifying predictors for HCAP persistently caused by MDR GNB is crucial for prescribing appropriate antibiotics. Copyright <feminine ordinal indicator> 2024, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
引用
收藏
页码:801 / 811
页数:11
相关论文
共 50 条
  • [21] Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients
    Shi, Shao Hua
    Kong, Hai Shen
    Jia, Chang Ku
    Zhang, Wen Jin
    Xu, Jian
    Wang, Wei Lin
    Shen, Yan
    Zhang, Min
    Zheng, Shu Sen
    CLINICAL TRANSPLANTATION, 2010, 24 (06) : 758 - 765
  • [22] Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia
    Ding, Peili
    Li, Hangyang
    Nan, Yuyu
    Liu, Chengwei
    Wang, Guobin
    Cai, Hongliu
    Yu, Wenqiao
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (04)
  • [23] Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria
    Avery, Lindsay M.
    Nicolau, David P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 325 - 338
  • [24] Challenges in Managing Multidrug-Resistant Gram-Negative Infections
    Varghese, George
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [25] Treatment guidelines for multidrug-resistant Gram-negative microorganisms
    Canton, Rafael
    Ruiz-Garbajosa, Patricia
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2023, 36 : 46 - 51
  • [26] Multidrug-resistant Gram-negative infections: the use of colistin
    Michalopoulos, Argyris S.
    Karatza, Dimitra C.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (09) : 1009 - 1017
  • [27] Genomic epidemiology of multidrug-resistant Gram-negative organisms
    Hawken, Shawn E.
    Snitkin, Evan S.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1435 (01) : 39 - 56
  • [28] Multidrug-Resistant Gram-Negative InfectionsWhat are the Treatment Options?
    Helen Giamarellou
    Garyphallia Poulakou
    Drugs, 2009, 69 : 1879 - 1901
  • [29] The role of fosfomycin for multidrug-resistant gram-negative infections
    Bassetti, Matteo
    Graziano, Elena
    Berruti, Marco
    Giacobbe, Daniele Roberto
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (06) : 617 - 625
  • [30] Treatment of Multidrug-Resistant Gram-Negative Infections in Children
    Hsu, Alice J.
    Tamma, Pranita D.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (10) : 1439 - 1448